PharmaCyte Biotech Inc (PMCB)

[BioNewton]

After reading Dr. Hidalgo's resume, no one is confused as to why PMCB is presenting at ASCO. It's because CiaB works and Dr. Hidalgo wants to take time of what is an incredibly busy schedule to show this treatment to large pharma. There is no better place than ASCO. A week ago we were told thru false whispers that PMCB isn't good enough to present at ASCO. Today it is announced that they will with the help of one of the greatest minds in PC research and now we are told it's not that big of a deal to be there. It cannot be both ways. It's more mature to admit when wrong. If you invest in Bio stocks normally, you understand how to follow the best Doctors in the country. That includes Dr. Matthias Lohr. If his presentation is on video take the time to listen to this genius talk about CiaB and feel how passionate he is about the treatment.

Ken Waggoner should be live via video the morning of June 2 at the Marcum Conference. This conference is all about money and investors. It is also a big deal for PMCB to be presenting there aside from anything else ever said.

By now all longs understand the pps here at PMCB. It will not go up until clinical trials start. This allows months to purchase shares of this great company for months for me. I hope it doesn't move until the buyout happens. In fact, Dr. Hidalgo's presentation should help solidify that too. Ignore the nervous ones on last ditch efforts and the false whispers.